Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MOV-FAS, TNI BioTech to build pharma plant in Nicaragua
TNIB, as part of its obligations under existing contracts as well as those under negotiation reached an agreement with MOV-FAS, will finance and construct a plant to produce
TNIB, as part of its obligations under existing contracts as well as those under negotiation reached an agreement with MOV-FAS, will finance and construct a plant to produce
Creative Edge Nutrition CEO Bill Chaaban said the acquisition is part of Creative Edge Nutrition’s expansion plan in the online supplement superstore field. ”With a team that has
The technology is complimentary to the early Beta cell destruction diagnostic that Islet Sciences has licensed last month. Islet Sciences chairman and CEO John Steel said in the
The IGS service uses Illumina’s HiSeq 2500 sequencing system, which is capable of completing a sequencing run on a whole human genome in one day. The service, which
The system is expected to protect against needlestick injury when using a prefilled syringe, according to West. West Syringe Systems Strategic Market Development vice president Glenn Thorpe said
According to the study data, in the intent-to-treat (ITT) population (n=264), the median TLUS was 46.0 hours for rifamycin SV MMX (n=199) compared with 68.0 hours for placebo
Eaton Scientific CEO Michael Borkowsk said Tropine 3 uses the convenience and dose control accuracy of a transdermal medicated patch delivery system. "Based upon the popular use of
Ondansetron Injection, USP is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin, and for prevention of
Ipsen has worked in close relation with the US Food and Drug Administration to maintain product supply as the product is a medical necessity. Increlex’s active principle, IGF-1
The contract has a maximum potential value of $1,511,407,737.78 if all optional activities are exercised over the duration of the contract. Under the terms of the contract, the